GPC1 and prostate cancer: Data in this study support the conclusion that the exposure of prostate cancer cells to CCM from HS-5 cells in which GPC-1 was inhibited increases the acquisition of a mesenchymal phenotype and increases the rate of cell migration after wound healing.